46,031 Shares in Bruker Corp. (BRKR) Acquired by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC bought a new stake in shares of Bruker Corp. (NASDAQ:BRKR) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 46,031 shares of the company’s stock, valued at approximately $1,047,000.
Other institutional investors have also bought and sold shares of the company. Acadian Asset Management LLC raised its position in shares of Bruker Corp. by 78.2% in the second quarter. Acadian Asset Management LLC now owns 6,243,776 shares of the company’s stock worth $141,986,000 after buying an additional 2,740,421 shares in the last quarter. State Street Corp raised its position in shares of Bruker Corp. by 27.2% in the first quarter. State Street Corp now owns 1,527,696 shares of the company’s stock worth $42,770,000 after buying an additional 326,527 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Bruker Corp. by 32.0% in the first quarter. Geode Capital Management LLC now owns 919,127 shares of the company’s stock worth $25,734,000 after buying an additional 222,648 shares in the last quarter. TIAA CREF Investment Management LLC raised its position in shares of Bruker Corp. by 43.1% in the first quarter. TIAA CREF Investment Management LLC now owns 755,012 shares of the company’s stock worth $21,140,000 after buying an additional 227,415 shares in the last quarter. Finally, Bogle Investment Management L P DE purchased a new position in shares of Bruker Corp. during the first quarter worth approximately $13,430,000. Institutional investors and hedge funds own 69.92% of the company’s stock.
Bruker Corp. (NASDAQ:BRKR) traded up 0.76% on Friday, reaching $21.27. 190,009 shares of the company’s stock traded hands. Bruker Corp. has a 52-week low of $16.99 and a 52-week high of $29.85. The firm’s 50-day moving average is $22.22 and its 200 day moving average is $24.71. The stock has a market capitalization of $3.43 billion, a PE ratio of 32.03 and a beta of 0.93.
Bruker Corp. (NASDAQ:BRKR) last issued its quarterly earnings results on Tuesday, August 2nd. The company reported $0.20 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.20. Bruker Corp. had a net margin of 6.86% and a return on equity of 22.66%. The firm earned $371.70 million during the quarter, compared to the consensus estimate of $409.57 million. During the same period in the prior year, the firm earned $0.19 EPS. The business’s revenue was down 6.1% on a year-over-year basis. Analysts forecast that Bruker Corp. will post $1.00 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Friday, September 23rd. Shareholders of record on Tuesday, September 6th were issued a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a yield of 0.76%. The ex-dividend date of this dividend was Thursday, September 1st. Bruker Corp.’s dividend payout ratio (DPR) is presently 24.24%.
A number of brokerages have commented on BRKR. Zacks Investment Research lowered shares of Bruker Corp. from a “buy” rating to a “hold” rating in a report on Tuesday, July 5th. Morgan Stanley set a $23.00 price objective on shares of Bruker Corp. and gave the stock a “hold” rating in a report on Wednesday, August 3rd. Mizuho cut their price objective on shares of Bruker Corp. from $28.00 to $23.00 and set a “neutral” rating on the stock in a report on Wednesday, August 3rd. Barclays PLC cut their price objective on shares of Bruker Corp. from $32.00 to $30.00 and set an “overweight” rating on the stock in a report on Wednesday, August 3rd. Finally, Cleveland Research lowered shares of Bruker Corp. from a “buy” rating to a “neutral” rating in a research note on Friday, July 22nd. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating, five have given a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $25.80.
In related news, Director Richard A. Packer purchased 10,000 shares of Bruker Corp. stock in a transaction on Wednesday, August 10th. The stock was purchased at an average cost of $21.97 per share, with a total value of $219,700.00. Following the acquisition, the director now directly owns 22,500 shares in the company, valued at $494,325. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Frank H. Laukien purchased 4,500 shares of Bruker Corp. stock in a transaction on Friday, August 5th. The stock was bought at an average cost of $22.17 per share, with a total value of $99,765.00. Following the completion of the acquisition, the chief executive officer now owns 37,658,733 shares in the company, valued at $834,894,110.61. The disclosure for this purchase can be found here. 35.80% of the stock is currently owned by company insiders.
Bruker Corp. Company Profile
Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company’s operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.
Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Corp. (NASDAQ:BRKR).
Receive News & Ratings for Bruker Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corp. and related companies with MarketBeat.com's FREE daily email newsletter.